Esco AsterMavors Cultivated Meat and Fermentation CDMO

Esco Aster is a Singapore-based cGMP contract research, development and manufacturing organisation (CRDMO) and an independent subsidiary of Esco Lifesciences Group. In July 2021 it became the first company to receive a Singapore Food Agency food processing licence to manufacture cell-based cultivated meat, helping alternative protein startups move from lab to market without building their own plants.

Through its AsterMavors unit, it offers end-to-end food ingredient and food product development and manufacturing. Services cover adherent cell culture on its Tide Motion bioreactors, suspension culture at 500 L with a planned 2 x 6,000 L pilot plant, and precision fermentation at 8,000 L capacity using fungi, bacteria, algae or plant cells, with strain development and antibiotic resistance-free hosts. Clients are cultivated meat, cultivated fat and precision fermentation companies.

• Tide Motion bioreactors: adherent cell culture with closed cell harvesting for cultivated meat and fat.
• Suspension culture: single-use bioreactors with microcarriers for biomass expansion.
• Precision fermentation: strain development, optimisation and scale-up for complementary proteins such as milk proteins.
• Hybrid products: combinations of plant-based ingredients with cultivated fat, fermented enzymes or flavourings.
• Downstream and analytics: processing and analytical control within designated food zones.
• Flexible business models: fee-for-service, milestone-based projects and partnered co-development.

• Vietnamese food companies piloting cultivated meat or seafood products for export markets.
• Ingredient startups outsourcing precision fermentation scale-up of dairy proteins or enzymes.
• Research institutes in Vietnam partnering on cell line development and process validation.

• Faster route to market: clients use licensed, certified capacity instead of building their own facilities.
• Food safety credentials: ISO 22000:2018 production since 2022 and the first FSSC 22000 certification for a cultivated meat facility in 2023.
• Scalable capacity: precision fermentation at 8,000 L and suspension culture from 500 L toward 6,000 L vessels.
• Capital efficiency: startups stay capex-light by relying on the company's biomanufacturing platforms.

Singapore has positioned itself as a regulatory and manufacturing hub for cultivated meat and precision fermentation in Asia. Most alternative protein startups lack capital for their own plants, creating demand for shared, food-grade contract manufacturing that can take products from pilot to commercial scale.

Independent subsidiary of Esco Lifesciences Group, based at Ayer Rajah Crescent, Singapore, with affiliates in Taiwan, Japan, the UK and the U.S. First Singapore Food Agency licence to manufacture cultivated meat (2021), ISO 22000:2018 (2022) and FSSC 22000 (2023). Runs accelerator programmes such as BioGarage with Leave a Nest.